Predictors of worsening kidney function and their relation to SGLT2 inhibitor dapagliflozin administration in type 2 diabetes mellitus patients with chronic heart failure

25 April 2024 (09:00 - 12:30)

Organised by:

Sign in to view the resources

Sign in to view the resources

About the speaker

Professor Alexander E Berezin

Paracelsus Private Medical University, Salzburg (Austria)

5 More presentations in this session

Presentation thumbnail

Acute cardiorenal syndrome: baseline comorbidities, biomarkers and prognostic significance

Doctor G. Aletras (Heraklion, GR)

Abstract Slides

Presentation thumbnail

Estimation of renal functional reserve in patients with preserved renal function and coronary microvascular dysfunction

Doctor M. Bora (Athens, GR) Doctor A. Sakalidis (Athens, GR)

Abstract Slides

Presentation thumbnail

Association between urinary concentrations of heavy metals and trace elements and renal function in Swiss adults: a cross-sectional study

Miss S. Xie (Lausanne, CH)

Abstract Slides

Presentation thumbnail

Effects of cardiac rehabilitation on the renal function in patients aged 75 years and older with moderate to severe renal dysfunction.

Doctor T. Hama (Hachioji, JP)

Abstract Slides

Presentation thumbnail

Does endothelial function differ among sexes in patients with diabetes or kidney disease?

Ms M. Renier (Leuven, BE)

Abstract Slides

Access the full session

Session thumbnail

Managing risk in the cardio-renal continuum

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Session

From genetic signatures to clinical implications

Congress Presentation

Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources